Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Wegovy's Medicare Part D Prospects: Four Million Lives And Counting?
May 02 2024
•
By
Cathy Kelly
Payers worry demand for Wegovy will be much higher now that there is some access to it in Part D. • Source: Shutterstock
More from Market Access
More from Pink Sheet